Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 347 (9007), 995-999
- https://doi.org/10.1016/s0140-6736(96)90144-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)Annals Of Oncology, 1994
- Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992Cancer, 1993
- Gastric cancer: a curable disease in Britain.BMJ, 1993
- Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patientsWorld Journal of Surgery, 1993
- Morbidity of Radical Lymphadenectomy in the Curative Resection of Gastric CarcinomaArchives of Surgery, 1991
- Gastric cancer: A 25-year reviewBritish Journal of Surgery, 1989
- Progress in gastric cancer surgery in Japan and its limits of radicalityWorld Journal of Surgery, 1987
- R2/3 gastrectomy for gastric carcinoma: An audited experience of a consecutive seriesBritish Journal of Surgery, 1985
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981